Predictive value of metabolic parameters and apparent diffusion coefficient derived from 18F-FDG PET/MR in patients with non-small cell lung cancer.


Journal

BMC medical imaging
ISSN: 1471-2342
Titre abrégé: BMC Med Imaging
Pays: England
ID NLM: 100968553

Informations de publication

Date de publication:
29 Oct 2024
Historique:
received: 27 06 2023
accepted: 30 09 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Multiple models intravoxel incoherent motion (IVIM) based To compare the value of Chest PET and IVIM scans were performed on 61 NSCLC patients using PET/MR. The maximum standard uptake value (SUV 61 NSCLC patients had an overall median OS of 18 months (14.75, 22.85) and a median PFS of 17 months (12.00, 21.75). Univariate analysis showed that pathological subtype, TNM stage, surgery, SUV MTV, D* and ADC are independent predicting factors affecting OS and PFS in NSCLC patients.

Sections du résumé

BACKGROUND BACKGROUND
Multiple models intravoxel incoherent motion (IVIM) based
OBJECTIVE OBJECTIVE
To compare the value of
METERIAL AND METHODS UNASSIGNED
Chest PET and IVIM scans were performed on 61 NSCLC patients using PET/MR. The maximum standard uptake value (SUV
RESULTS RESULTS
61 NSCLC patients had an overall median OS of 18 months (14.75, 22.85) and a median PFS of 17 months (12.00, 21.75). Univariate analysis showed that pathological subtype, TNM stage, surgery, SUV
CONCLUSION CONCLUSIONS
MTV, D* and ADC are independent predicting factors affecting OS and PFS in NSCLC patients.

Identifiants

pubmed: 39472782
doi: 10.1186/s12880-024-01445-8
pii: 10.1186/s12880-024-01445-8
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D
Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

290

Subventions

Organisme : Henan provincial science and technology research projects
ID : 212102310689
Organisme : Henan Province Medical Science and technology public relations plan joint project
ID : LHGJ20210001
Organisme : Zhengzhou Collaborative Innovation Major Project
ID : 20XTZX05015
Organisme : medical science and technology project of Henan Province
ID : SBGJ202101002

Informations de copyright

© 2024. The Author(s).

Références

Ann Nucl Med. 2022 Apr;36(4):393-400
pubmed: 35084711
AJR Am J Roentgenol. 2020 Feb;214(2):437-445
pubmed: 31714848
Eur Radiol. 2020 Feb;30(2):1191-1201
pubmed: 31493211
Sci Rep. 2022 Apr 20;12(1):6523
pubmed: 35444193
J Natl Compr Canc Netw. 2012 Oct 1;10(10):1236-71
pubmed: 23054877
Clin Cancer Res. 2009 Sep 15;15(18):5861-8
pubmed: 19737951
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Clin Nucl Med. 2021 Aug 1;46(8):621-626
pubmed: 34034316
Radiology. 1988 Aug;168(2):497-505
pubmed: 3393671
Radiology. 2013 Aug;268(2):318-22
pubmed: 23882093
Transl Lung Cancer Res. 2021 Aug;10(8):3671-3681
pubmed: 34584865
Strahlenther Onkol. 2019 Aug;195(8):707-718
pubmed: 30610356
Magn Reson Imaging. 2013 Feb;31(2):235-46
pubmed: 22902469
Front Oncol. 2021 Jun 04;11:671912
pubmed: 34150635
Behav Res Methods. 2016 Sep;48(3):994-1003
pubmed: 26182855
Technol Cancer Res Treat. 2010 Feb;9(1):5-20
pubmed: 20082526
AJR Am J Roentgenol. 2007 Jun;188(6):1622-35
pubmed: 17515386
Eur Radiol. 2014 Jul;24(7):1506-13
pubmed: 24744198
AJR Am J Roentgenol. 2012 Jan;198(1):75-82
pubmed: 22194481
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):241-51
pubmed: 25193652
Cancer Res. 2017 Jul 1;77(13):3491-3501
pubmed: 28487383
Am J Nucl Med Mol Imaging. 2012;2(4):458-74
pubmed: 23145362
Eur Radiol. 2014 Aug;24(8):1914-22
pubmed: 24788038
J Magn Reson Imaging. 2022 May;55(5):1376-1390
pubmed: 34723413
J Magn Reson Imaging. 2023 Jul;58(1):174-186
pubmed: 36971493
Eur Radiol. 2016 Feb;26(2):556-66
pubmed: 26003791
Front Oncol. 2020 Sep 11;10:1763
pubmed: 33042822
Q J Nucl Med Mol Imaging. 2012 Apr;56(2):191-201
pubmed: 22402822
Trends Mol Med. 2010 Nov;16(11):508-15
pubmed: 20851684
J Magn Reson Imaging. 2020 Dec;52(6):1811-1826
pubmed: 32621405
Clin Cancer Res. 2019 Jun 1;25(11):3266-3275
pubmed: 31010833
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983
pubmed: 28689281
Clin Lung Cancer. 2021 Sep;22(5):461-468
pubmed: 33931316
Ann Surg Oncol. 2010 Jan;17(1):115-22
pubmed: 19826877
Radiology. 2023 Apr;307(2):e221598
pubmed: 36692397
Radiol Med. 2011 Aug;116(5):720-33
pubmed: 21293944
Tuberk Toraks. 2012;60(3):207-17
pubmed: 23030745
Contrast Media Mol Imaging. 2021 Nov 22;2021:7528971
pubmed: 34887713
J Cancer Res Clin Oncol. 2010 Jun;136(6):883-9
pubmed: 19936788
Front Oncol. 2022 Jul 29;12:873669
pubmed: 35965564
Br J Radiol. 2019 Jan;92(1093):20180379
pubmed: 30209954
Ann Clin Lab Sci. 2022 May;52(3):511-525
pubmed: 35777803
Med Oncol. 2018 Apr 9;35(5):66
pubmed: 29633024

Auteurs

Han Jiang (H)

Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

Ziqiang Li (Z)

Department of Magnetic Resonance, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.

Nan Meng (N)

Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

Yu Luo (Y)

Zhengzhou University People's Hospital, Zhengzhou, Henan, China.

Pengyang Feng (P)

Henan University People's Hospital, Zhengzhou, Henan, China.

Fangfang Fu (F)

Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

Yang Yang (Y)

Beijing United Imaging Research Institute of Intelligent Imaging, United Imaging Healthcare Group, Beijing, China.

Jianmin Yuan (J)

Central Research Institute, United Imaging Healthcare Group, Shanghai, China.

Zhe Wang (Z)

Central Research Institute, United Imaging Healthcare Group, Shanghai, China.

Meiyun Wang (M)

Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China. mywang@zzu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH